Atezolizumab vs Dapagliflozin

## Atezolizumab vs Dapagliflozin: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Dapagliflozin**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Dapagliflozin — 12.9 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Dapagliflozin — C21H25ClO6.

**Molecular Weight**: Atezolizumab — N/A; Dapagliflozin — 408.8730 g/mol.

**Type**: Atezolizumab — Antibody; Dapagliflozin — Small molecule.